| Title: | Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohort |
| Journal: | Cancer |
| Published: | 20 Apr 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35442525/ |
| DOI: | https://doi.org/10.1002/cncr.34245 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262755 |
Publication 7146
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
10 Keywords
- Antineoplastic Agents, Hormonal
- Aromatase Inhibitors
- Biological Specimen Banks
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Female
- Humans
- Parkinson Disease
- Tamoxifen
- United Kingdom
2 Authors
- Steven Lehrer
- Peter H Rheinstein
1 Application
| Application ID | Title |
|---|---|
| 57245 | Does homozygous Christchurch mutation in apoE3 delay onset of Alzheimer's disease |
Enabling scientific discoveries that improve human health